A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer

FASEB Journal

Volumn 23, Issue 7, 2009, Pages 2274-2287

  Yu, Ke Da ^a   Di, Gen Hong ^a   Fan, Lei ^a   Wu, Jiong ^a   Hu, Zhen ^a   Shen, Zhen Zhou ^a   Huang, Wei ^b   Shao, Zhi Ming ^a  

^a FUDAN UNIVERSITY   (China)

^b CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

Author keywords

AP 2; Functional verification; Meta analysis; Risk pattern

Indexed keywords

DNA; GLUTATHIONE TRANSFERASE M1; MESSENGER RNA; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR AP 2ALPHA; UNCLASSIFIED DRUG; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE TRANSFERASE;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVITY; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENE FREQUENCY; GENETIC LINKAGE; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE; ASIAN; BREAST TUMOR; CHINA; GENETIC POLYMORPHISM; GENETICS; META ANALYSIS; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; TUMOR CELL LINE;

ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CHINA; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-2;

EID: 68549089044     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.08-124073     Document Type: Article

References (39)

1. Yager, J. D., and Davidson, N. E. (2006) Estrogen carcinogenesis in breast Cancer N. Engl. J. Med. 354, 270-282
2. Cavalieri, E. L., Stack, D. E., Devanesan, P. D., Todorovic, R., Dwivedy, I., Higginbotham, S., Johansson, S. L., Patil, K. D., Gross, M. L., Gooden, J. K., Ramanathan, R., Cerny, R. L., and Rogan E. G. (1997) Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc. Natl. Acad. Sci. U. S. A. 94, 10937-10942
3. Dunning, A. M., Healey, C. S., Pharoah, P. D., Teare, M. D., Ponder, B. A., and Easton, D. F. (1999) A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 8, 843-854 (Pubitemid 29508718)
4. Xiong, P., Bondy, M. L., Li, D., Shen, H., Wang, L. E., Singletary, S. E., Spitz, M. R., and Wei, Q. (2001) Sensitivity to benzo-(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study. Cancer Res. 61, 8465-8469 (Pubitemid 33131126)
5. Xu, X., Gammon, M. D., Zeisel, S. H., Lee, Y. L., Wetmur, J. G., Teitelbaum, S. L., Bradshaw, P. T., Neugut, A. I., Santella, R. M., and Chen, J. (2008) Choline metabolism and risk of breast cancer in a population-based study. FASEB J. 22, 2045-2052 (Pubitemid 351811480)
6. Parl, F. F. (2005) Glutathione S-transferase genotypes and cancer risk. Cancer Lett. 221, 123-129
7. Vogl, F. D., Taioli, E., Maugard, C., Zheng, W., Pinto, L. F., Ambrosone, C., Parl, F. F., Nedelcheva-Kristensen, V., Rebbeck, T. R., Brennan, P., and Boffetta, P. (2004) Glutathione S-transferases M1, T1, and P1 and breast cancer: a pooled analysis. Cancer Epidemiol. Biomarkers Prev. 13, 1473-1479 (Pubitemid 39202314)
8. Wilson, M. H., Grant, P. J., Hardie, L. J., and Wild, C. P. (2000) Glutathione S-transferase M1 null genotype is associated with a decreased risk of myocardial infarction. FASEB J. 14, 791-796
9. Brasch-Andersen, C., Christiansen, L., Tan, Q., Haagerup, A., Vestbo, J., and Kruse, T. A. (2004) Possible gene dosage effect of glutathione-S- transferases on atopic asthma: using real-time PCR for quantification of GSTM1 and GSTT1 gene copy numbers. Hum. Mutat. 24, 208-214 (Pubitemid 39095597)
10. Roodi, N., Dupont, W. D., Moore, J. H., and Parl, F. F. (2004) Association of homozygous wild-type glutathione S-transferase M1 genotype with increased breast cancer risk. Cancer Res. 64, 1233-1236 (Pubitemid 38235587)
11. Santen, R. J., and Mansel, R. (2005) Benign breast disorders. N. Engl. J. Med. 353, 275-285
12. Yu, K. D., Di, G. H., Wu, J., Lu, J. S., Shen, K. W., Shen, Z. Z., and Shao, Z. M. (2007) Development and trends of surgical modalities for breast cancer in china: a review of 16-year data. Ann. Surg. Oncol. 14, 2502-2509 (Pubitemid 47389574)
13. Antoniou, A. C., and Easton, D. F. (2003) Polygenic inheritance of breast cancer: Implications for design of association studies. Genet. Epidemiol. 25, 190-202 (Pubitemid 37296594)
14. Li, W. F., Hu, Z., Rao, N. Y., Song, C. G., Zhang, B., Cao, M. Z., Su, F. X., Wang, Y. S., He, P. Q., Di, G. H., Shen, K. W., Wu, J., Lu, J. S., Luo, J. M., Liu, X. Y., Zhou, J., Wang, L., Zhao, L., Liu, Y. B., Yuan, W. T., Yang, L., Shen, Z. Z., Huang, W., and Shao Z. M. (2008) The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified. Breast Cancer Res. Treat. 110, 99-109
15. Chacko, P., Joseph, T., Mathew, B. S., Rajan, B., and Pillai, M. R. (2005) Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome. Mutat. Res. 581, 153-163 (Pubitemid 40255903)
16. Harada, S., Tachikawa, H., and Kawanishi, Y. (2001) Glutathione S-transferase M1 gene deletion may be associated with susceptibility to certain forms of schizophrenia. Biochem. Biophys. Res. Commun. 281, 267-271 (Pubitemid 32928147)
17. Liu, J. B., Li, M., Chen, H., Zhong, S. Q., Yang, S., Du, W. D., Hao, J. H., Zhang, T. S., Zhang, X. J., and Zeegers, M. P. (2007) Association of vitiligo with HLA-A2: a meta-analysis. J. Eur. Acad. Dermatol. Venereol. 21, 205-213
18. Fryer, A. A., Zhao, L., Alldersea, J., Pearson, W. R., and Strange, R. C. (1993) Use of site-directed mutagenesis of allele-specific PCR primers to identify the GSTM1 A, GSTM1 B, GSTM1 A,B and GSTM1 null polymorphisms at the glutathione S-transferase, GSTM1 locus. Biochem. J. 295(Pt. 1), 313-315 (Pubitemid 23298343)
19. Gabriel, S. B., Schaffner, S. F., Nguyen, H., Moore, J. M., Roy, J., Blumenstiel, B., Higgins, J., DeFelice, M., Lochner, A., Faggart, M., Liu-Cordero, S. N., Rotimi, C., Adeyemo, A., Cooper, R., Ward, R., Lander, E. S., Daly, M. J., and Altshuler, D. (2002) The structure of haplotype blocks in the human genome. Science 296, 2225-2229 (Pubitemid 34680308)
20. Moshynska, O., Moshynskyy, I., Misra, V., and Saxena, A. (2005) G125A single-nucleotide polymorphism in the human BAX promoter affects gene expression. Oncogene 24, 2042-2049 (Pubitemid 40516197)
21. Danilition, S. L., Frederickson, R. M., Taylor, C. Y., and Miyamoto, N. G. (1991) Transcription factor binding and spacing constraints in the human β-actin proximal promoter. Nucleic Acids Res. 19, 6913-6922
22. Mitchell, P. J., Wang, C., and Tjian, R. (1987) Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen. Cell 50, 847-861
23. Zhang, X., Miao, X., Tan, W., Ning, B., Liu, Z., Hong, Y., Song, W., Guo, Y., Zhang, X., Shen, Y., Qiang, B., Kadlubar, F. F., and Lin, D. (2005) Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology 129, 565-576 (Pubitemid 41096644)
24. Imagawa, M., Chiu, R., and Karin, M. (1987) Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. Cell 51, 251-260
25. Li, D. Q., Wang, L., Fei, F., Hou, Y. F., Luo, J. M., Zeng, R., Wu, J., Lu, J. S., Di, G. H., Ou, Z. L., Xia, Q. C., Shen, Z. Z., and Shao, Z. M. (2006) Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry. Proteomics 6, 3352-3368 (Pubitemid 43886152)
26. Pfaffl, M. W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45
27. Bonetti, M., and Gelber, R. D. (2000) A graphical method to assess treatment-covariate interactions using the Cox model on subsets of the data. Stat. Med. 19, 2595-2609 (Pubitemid 30727393)
28. Egan, K. M., Cai, Q., Shu, X. O., Jin, F., Zhu, T. L., Dai, Q., Gao, Y. T., and Zheng, W. (2004) Genetic polymorphisms in GSTM1, GSTP1, and GSTT1 and the risk for breast cancer: results from the Shanghai Breast Cancer Study and meta-analysis. Cancer Epidemiol. Biomarkers Prev. 13, 197-204 (Pubitemid 38222549)
29. Park, S. K., Yim, D. S., Yoon, K. S., Choi, I. M., Choi, J. Y., Yoo, K. Y., Noh, D. Y., Choe, K. J., Ahn, S. H., Hirvonen, A., and Kang, D. (2004) Combined effect of GSTM1, GSTT1, and COMT genotypes in individual breast cancer risk. Breast Cancer Res. Treat. 88, 55-62 (Pubitemid 39524445)
30. Jiang, J. G., DeFrances, M. C., Machen, J., Johnson, C., and Zarnegar, R. (2000) The repressive function of AP2 transcription factor on the hepatocyte growth factor gene promoter. Biochem. Biophys. Res. Commun. 272, 882-886 (Pubitemid 30420730)
31. Sull, J. W., Ohrr, H., Kang, D. R., and Nam, C. M. (2004) Glutathione S-transferase M1 status and breast cancer risk: a meta-analysis. Yonsei Med. J. 45, 683-689 (Pubitemid 39263993)
32. Ambrosone, C. B., Freudenheim, J. L., Graham, S., Marshall, J. R., Vena, J. E., Brasure, J. R., Laughlin, R., Nemoto, T., Michalek, A. M., Harrington, A., Ford, T. D., and Shields P. G. (1995) Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res. 55, 3483-3485
33. Helzlsouer, K. J., Selmin, O., Huang, H. Y., Strickland, P. T., Hoffman, S., Alberg, A. J., Watson, M., Comstock, G. W., and Bell, D. (1998) Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J. Natl. Cancer Inst. 90, 512-518 (Pubitemid 28182544)
34. Mitrunen, K., Jourenkova, N., Kataja, V., Eskelinen, M., Kosma, V. M., Benhamou, S., Vainio, H., Uusitupa, M., and Hirvonen, A. (2001) Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer. Cancer Epidemiol. Biomarkers Prev. 10, 229-236 (Pubitemid 34288534)
35. Gyorffy, B., Kocsis, I., and Vasarhelyi, B. (2004) Missed calculations and new conclusions: re-calculation of genotype distribution data published in Journal of Investigative Dermatology, 1998-2003. J. Invest. Dermatol. 122, 644-646 (Pubitemid 38471330)
36. Deng, H. W., Chen, W. M., and Recker, R. R. (2001) Population admixture: detection by Hardy-Weinberg test and its quantitative effects on linkage-disequilibrium methods for localizing genes underlying complex traits. Genetics 157, 885-897
37. Reed, D. J. (1990) Glutathione: toxicological implications. Annu. Rev. Pharmacol. Toxicol. 30, 603-631
38. Widersten, M., Pearson, W. R., Engstrom, A., and Mannervik, B. (1991) Heterologous expression of the allelic variant mu-class glutathione transferases mu and psi. Biochem. J. 276 (Pt 2), 519-524
39. Moyer, A. M., Salavaggione, O. E., Hebbring, S. J., Moon, I., Hildebrandt, M. A., Eckloff, B. W., Schaid, D. J., Wieben, E. D., and Weinshilboum, R. M. (2007) Glutathione S-transferase T1 and M1: gene sequence variation and functional genomics. Clin. Cancer Res. 13, 7207-7216 (Pubitemid 350276908)